DNA replisome-related genes, MCM2, MCM4, MCM6, MCM7, CDC45, and CDC7, were identified as upregulated in the SCLC tissues and may be potential therapeutic targets for treatment-resistant SCLC cells. This evidence concerns the gene MCM7 and small cell lung carcinoma.